Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | APEI | CVSA |
|---|---|---|
| Price | $46.05 | $127.30 |
| Change today | ▼ 0.37% | ▼ 0.06% |
| Market cap | $842.79M | $4.31B |
| Return, 3 months | -20.4% | -3.1% |
| Return, year to date | +21.8% | +23.0% |
| Return, 1 year | +23.8% | -13.0% |
| P/E (TTM) | 19.0 | 18.1 |
| P/B | 2.7 | 3.0 |
| P/E percentile vs own 5y | 45th | 57th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +5.5% | +9.7% |
| Net profit growth (YoY) | +117.4% | +32.3% |
| Gross margin | 55.9% | 57.3% |
| Operating margin | 10.2% | 19.9% |
| Net margin | 6.8% | 12.9% |
| Return on equity | 15.6% | 17.5% |
| Analyst target vs. price | +31.9% | +24.7% |
| Analyst buy share | 80% | 75% |
| RSI (14) | 59 | 54 |
| 30-day volatility | 31.5% | 29.5% |
| Max drawdown, 1 year | -33.3% | -42.1% |
| Trend read | Leaning bullish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
